Monday, December 04, 2006
Pfizer's drug failure puts focus on strategic deals - MSNBC
¶ 5:05 PM 
 Earthtimes.org | Pfizer's drug failure puts focus on strategic deals MSNBC - By Christopher Bowe in New York. Pfizer the US drug maker is set to focus more on strategic acquisitions as investor concern over the failure of its most important pipeline drug torcetrapib sent its shares plunging 12 per cent on Monday. Pfizer Shares Lose $23 Billion After Drug's Failure (Update8) Pfizer shares sink after key drug halted |
RSS :
